Quick Search

PHDS HEALTHCARE RESEARCH Co., Ltd. (CRO) is a CRO company serving the world, a national high-tech enterprise, and one of the leading contract research institutions (Contract Research Organization) in the industry.

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News

The CEO of PHDS was invited to attend the 09 China-US Economic Cooperation Summit to discuss cooperation matters with American mayors.


Release time:

2009-07-01

PHDS, as the "Designated Cooperation Enterprise of China" for the "China-US Small and Medium Enterprises Cooperation Program", had its CEO and international business executives attend the "2009 China-US Economic Cooperation Summit" held in Beijing on July 20, 2009, by invitation.

The CEO of PHDS was invited to attend the 09 China-US Economic Cooperation Summit to discuss cooperation matters with American mayors.

PHDS, as a "designated cooperative enterprise in China" for the "China-U.S. Small and Medium Enterprises Cooperation Program," had its CEO and international business executives attend the "2009 China-U.S. Economic Cooperation Summit" held in Beijing on July 20, 2009, at the invitation of the organizers.

At this meeting, PHDS executives had productive exchanges and discussions with mayors from three important U.S. cities and some business representatives from foreign embassies in China. The U.S. city mayors who met with PHDS executives were: Mr. Robert D. Coble, Vice Mayor of Columbia, U.S.; Ms. Sue Greenward, Mayor of Davis, California; and Mr. Tom Means, Mayor of Mountain View, California. Both sides introduced their cooperation plans and target projects. Through the discussions, both parties gained a preliminary understanding and agreed to continue communication, exchange information, and deepen understanding to achieve substantial progress in cooperation as soon as possible.

At the meeting, PHDS also had friendly talks with business representatives from the Dutch Embassy in China.

This summit was jointly organized by the China-U.S. International Cooperation and Exchange Promotion Association, the Global Small and Medium Enterprises Alliance, the U.S. Conference of Mayors, and the National High-Tech City and County Industrial Economic Development Research Center, among other China-U.S. institutions, in Beijing. Attendees included officials from U.S. embassies in China, commercial counselors from Japan and South Korea, the chairman of the Global Small and Medium Enterprises Alliance, the president of the China-U.S. International Cooperation and Exchange Promotion Association, representatives from business associations in Hong Kong and Taiwan, five mayors from South Carolina, California, and other regions, over 30 representatives from U.S. business delegations, as well as leaders from relevant Chinese ministries, local government investment and foreign affairs departments, and hundreds of Chinese entrepreneurs.

The theme of this summit was: jointly exploring how small and medium cities and enterprises in China and the U.S. can achieve mutually beneficial cooperation against the backdrop of the financial crisis. This summit, held against the backdrop of the global financial crisis, carries even greater historical significance. Mainstream media at home and abroad reported on this meeting. The conference was a complete success.

Keyword:

Relevant regulations and policies


Key points and judgment principles for the quality management of non-clinical research of drugs

In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."

2024-11-22

Technical requirements for the latest declaration data electronic disc

In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.

2024-11-22

PHDS was elected as: Vice President unit of the China Food and Drug Enterprise Quality Safety Promotion Association

In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.

2024-11-22

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

2024-11-22